Chronic lymphocytic leukemia

As new and more-effective treatments have been developed, bone marrow transplant has become less common for treating chronic lymphocytic leukemia . However, an allogeneic bone marrow transplant may be a treatment option for some people with relapsed or refractory chronic lymphocytic leukemia .

Many treatments are available for chronic lymphocytic leukemia , and recent breakthroughs and clinical trials are under investigation. Learn about your options.
Chronic Lymphocytic Leukemia Treatment (PDQ)

Chronic lymphocytic leukemia (CLL) treatment options can include observation, steroids, chemotherapy, targeted therapy, and/or stem cell transplant. Get detailed information about newly diagnosed and recurrent CLL and available treatment modalities in this summary for clinicians.
Chronic lymphocytic leukemia (CLL) treatment can include observation, steroids, radiation therapy, chemotherapy, surgery, or targeted therapy. Learn more about the diagnosis, prognosis, and treatment of newly diagnosed or recurrent CLL in this expert-reviewed summary.

Updates in the management of newly diagnosed chronic lymphocytic leukemia
The options for frontline chronic lymphocytic leukemia (CLL) treatment continue to expand. Therapies include monotherapy with a Bruton's tyrosine kinase inhibitor (BTKi), doublet therapies such as venetoclax with intravenous obinutuzmab or an oral BTKi, and triplet therapy combining BTKi, venetoclax, and CD20 antibody. Treatment duration also is increasingly variable, from fixed duration to ...
New data presented at the ASH Annual Meeting 2025 are suggesting that fixed-duration vs continuous targeted treatment may be acceptable for previously untreated chronic lymphocytic leukemia (CLL). 1 A separate study presented at the meeting demonstrated benefits of lisaftoclax monotherapy after failure with Bruton tyrosine kinase inhibitor (BTKis). 2 Another study comparing pirtobrutinib with ...

New optimism in treatment for people with chronic lymphocytic leukemia ...
A diagnosis of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) can produce anxiety and can be confusing. You may wonder how much time…
Research on chronic lymphocytic leukemia (CLL) is being done in many medical centers and other institutions around the world. Each year, scientists find out more about what causes the disease, how to test for it, and how to better treat it. Most experts agree that treatment in a clinical trial should be considered for any person with CLL.

Key Details About New Treatments For Chronic Lymphocytic Leukemia
Treatment of chronic lymphocytic leukemia (CLL) currently consists of two main approaches — continuous therapy with Bruton's tyrosine kinase inhibitors and fixed-duration regimens combining ...








The treatment landscape for chronic lymphocytic leukemia (CLL) has changed dramatically since FDA approval of the first-generation Bruton's tyrosine kinase (BTK) inhibitor ibrutinib for CLL in 2014.